Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced pancreatic ductal adenocarcinoma (PDA).
Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the ...
In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...
GlobalData on MSN1d
Novocure seeks approval after pancreatic cancer wearable scores at Phase IIINovocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...
Novocure this week announced positive topline results from its Phase 3 trial of its Tumor Treating Fields for pancreatic cancer.
The Phase 3 PANOVA-3 trial has shown that adding Tumor Treating Fields therapy to standard chemotherapy improved survival in ...
A doctor has issued a warning about a common type of cancer with one of the lowest survival rates, but offered fresh hope as ...
Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.
Mr Broad dedicated 25 years to Harrogate's largest primary school and helped to secure its most recent ‘outstanding’ ...
Pancreatic cancer is rare but life-threatening At the same time it can be asymptomatic in the early stages making it ...
In mice, a ketogenic diet remodeled the translatome of pancreatic cancer cells, rendering them vulnerable to targeted therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback